CCK Strategies Revenue and Competitors
Estimated Revenue & Valuation
- CCK Strategies's estimated annual revenue is currently $34.4M per year.
- CCK Strategies's estimated revenue per employee is $231,000
Employee Data
- CCK Strategies has 149 Employees.
- CCK Strategies grew their employee count by 7% last year.
CCK Strategies's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Financial Officer | Reveal Email/Phone |
2 | Managing Director | Reveal Email/Phone |
3 | Managing Director | Reveal Email/Phone |
4 | Consultant & HR Director | Reveal Email/Phone |
5 | Tax Manager | Reveal Email/Phone |
6 | Tax Project Manager | Reveal Email/Phone |
7 | Tax Project Manager | Reveal Email/Phone |
8 | Tax Project Manager | Reveal Email/Phone |
9 | Tax Manager | Reveal Email/Phone |
10 | Tax Manager | Reveal Email/Phone |
CCK Strategies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $28.4M | 125 | 16% | N/A | N/A |
#2 | $119.3M | 388 | 13% | N/A | N/A |
What Is CCK Strategies?
Celebrating the firm’s 20th anniversary, CCK Strategies is a non-traditional firm founded by three partners motivated to build a new type of CPA firm. CCK is led by partners: John Curzon, Terry Cumbey, Eric Kunkel, Jeff Frable, Kayce Nelson and Aaron Spoon. In 2017, Accounting Today named CCK Strategies as one of the 2017 Accounting Today’s Best Accounting Firms to Work For. It was CCK’s fourth consecutive year to receive the award.
keywords:N/AN/A
Total Funding
149
Number of Employees
$34.4M
Revenue (est)
7%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CCK Strategies News
2022-04-17 - Protective autophagy decreases lorlatinib cytotoxicity through
Foxo3a-dependent inhibition of apoptosis in NSCLC
... enable the development of more efficacious therapeutic strategies. ... in vitro and in vivo was assessed using CCK-8, colony formation,...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $40.2M | 149 | 3% | N/A |
#2 | $36.3M | 150 | 15% | N/A |
#3 | $54.5M | 150 | 9% | N/A |
#4 | N/A | 153 | 0% | $75M |
#5 | $37M | 153 | 13% | N/A |